Amgen Assist 360™ is a single place for patients, caregivers, and healthcare professionals to go to find the support, tools, and resources most important to them. 

Call 1-888-4ASSIST (1-888-427-7478)

Program Info:  amgenassist360

Astellas Pharma Support Solutions offers access and reimbursement support to help patients overcome challenges to accessing Astellas products. Reimbursement Hotline is Toll-free: 1(800) 477-6472

Program Info:  Astellas Pharma Support Solutions

As a part of our commitment to providing support to healthcare professionals and patients, we’ve developed resources for various stages of patient care. Visit the Astellas Resource Portal.

Reimbursement Contact:

Kevin Kobylinski, Access and Reimbursement Manager
NH/VT/ME/MA/CT/RI
C: 603-502-8175
E-mail: kevin.kobylinski@Astellas.com 

Drugs: PADCEV™ (enfortumab vedotin-ejfv), Xospata® (gilteritinib), Xtandi® (enzalutamide)

At AstraZeneca, we believe it’s not enough for us to simply make medicines. We have to make sure that the people who need those medicines can get them. It’s why we’ve offered patient assistance programs for over 30 years. 

(1) Access 360 provides:  

• Assistance with understanding patient insurance coverage and pharmacy options
• Prior authorization support
• Claims and appeal process support
• Resources for patients

Program Info: AstraZeneca Access 360

(2) The AstraZeneca AZ&ME Prescription Savings Program is helping patients who are having trouble affording their AstraZeneca medicines. This site will guide you through the AZ&ME application process to see if you are eligible for the program. Contact: 1-800-AZandME

Program Info: AZ&ME

(3) To assist with out-of-pocket costs, AstraZeneca’s Co-pay Savings Program is available for eligible commercially insured patients receiving select AstraZeneca specialty medications.

Program Info: AZpatientsupport.com

Reimbursement Contact:

Jenifer N. McNulty

Senior Field Reimbursement Manager, ME/VT/NH/RI/Eastern MA

C: 617-818-3517

E-mail: Jenifer.mcnulty@astrazeneca.com

Joann Dousa

Field Reimbursement Manager, Upstate NY/CT/Western MA

C: 508-813-2834

E-mail: Joann.dousa@astrazeneca.com

Products: Calquence , Enhertu, Imfinzi, Imjudo, Lynparza, Tagrisso, TruQap 

The AVEO ACE Access Center of Excellence is a comprehensive program dedicated to providing personalized support to patients and their loved ones throughout the FOTIVDA treatment journey

Contact: 1-833-FOTIVDA (1-833-368-4832)

Program Info:  AVEO ACE

Visit the website to learn more about Blueprint Medicine’s patient support program, YourBlueprint. This website provides information about access and reimbursement, financial assistance, how to order your patient’s prescribed drug, and helpful resources.

Unbranded/Disease Awareness: https://itssmthing.com/

Program Info: YourBlueprint

Reimbursement Contact:

Fred Richards, Associate Director, Regional Marketing, New England and New York

Blueprint Medicines

E-mail: Frichards@blueprintmedicines.com

Cell: 781-258-1457

Drugs:

• Ayvakit (avapritinib) Indicated for: Systemic Mastocytosis (Indolent SM, Smoldering SM, Advanced SM, SM with AHN), and PDGFRA GIST. https://ayvakit.com
• Gavreto (pralsetinib) – Indicated for: RET+ mNSCLC and RET+ advanced or metastatic thyroid carcinoma. https://www.gavreto.com

Bristol-Myers Squibb is committed to helping appropriate patients get access to our medications by providing access and reimbursement services. Contact: 1-800-861-0048

• Understanding Your Healthcare Benefits
• Patient Reimbursement Process Map
• BMS Access Support Patient Brochure

Program Info:  BMS Access Support

Access Central is committed to helping you get the Daiichi Sankyo medication you need and is an important resource for you and your doctor. We provide support tailored to your unique needs, including:

• Help getting the medication you need by working with your insurance company
• Financial assistance programs for eligible people with and without insurance
• Assistance with understanding your insurance coverage

Contact: 1-866- 4-DSI-NOW (1-866-437-4669)

Program Info: DAIICHI SANKYO ACCESS CENTRAL

At Eisai, everything we do is guided by a simple principle: patients and their families come first and we have a responsibility to listen to and learn from them. We call this human health care, or hhc.

Benefits investigation, Financial assistance, Eisai Patient Support Program Hotline, Appeal Information, and Prior Authorization Information

Program Info: Patient Support for HCPs|LENVIMA (lenvatinib) Reimbursement (eisaipatientsupport.com)

Eisai Assistance Program: For program and eligibility information, and to review the program terms and conditions, please visit eisaireimbursement.com or call 1-866-61-EISAI (1-866-613-4724).

Reimbursement Contact:

Niya Prabhu, Sr Manager, Access & Reimbursement

E-mail: niya_prabhu@eisai.com

Phone: 917.232.5956

Drugs: Lenvima and Halaven

Exelixis Access Services (EASE). Access. Assistance. Along The Journey.

Exelixis Access Services® (EASE) provides a variety of support to help your patients start treatment quickly. EASE can help meet the unique needs of your patients and practice at each step along the access journey.

Contact: 1-844-900-EASE (3273)

Program Info: Ease.us

Genentech is dedicated to helping patients. Since Genentech started providing access and reimbursement support almost 20 years ago, Genentech has helped more than 2 million patients access the medicines they need. 

Contact: 855-MYCOPAY (855-692-6729)

Patient Assistance Programs via Genentech Access Solutions include:

Genentech BioOncology Co-Pay Card - The Genentech BioOncology Co-Pay Card is for commercially insured patients receiving treatment with a Genentech BioOncology product that meet certain eligibility criteria. 

Co-Pay Assistance Foundations - If privately or publicly insured patients have difficulty paying their co-pay, co-insurance or other expenses, Genentech Access Solutions can refer them to a co-pay assistance foundation supporting their disease.

Genentech Patient Foundation - The Genentech Patient Foundation was established to help patients with unmet medical needs who are uninsured or rendered uninsured by payer denial and who meet specific criteria to receive their prescription free of charge.

Infused Products: AVASTIN® (bevacizumab) , GAZYVA® (obinutuzumab)HERCEPTIN® (trastuzumab), KADCYLA® (ado-trastuzumab emtansine), PERJETA® (pertuzumab), POLIVY™ (POLATUZUMAB VEDOTIN-PIIQ), RITUXAN® (rituximab), TECENTRIQ® (atezolizumab)

Oral Products: ALECENSA® (alectinib), COTELLIC® (cobimetinib), ERIVEDGE® (vismodegib),GAVRETO (pralsetinib),ROZLYTREK® (entrectinib), TARCEVA® (erlotinib), VENCLEXTA™ (venetoclax) ZELBORAF® (vemurafenib)

Subcutaneous Products: ​HERCEPTIN HYLECTA™ (TRASTUZUMAB AND HYALURONIDASE-OYSK), ​PHESGO (pertuzumab, trastuzumab, and hyaluronidase-zzxf), RITUXAN HYCELA™ (rituximab/hyaluronidase human)

TRODELVY ACCESS SUPPORT is a patient access and reimbursement support program. 

Please click to see full Prescribing Information, including BOXED WARNING.

Program Info: www.TRODELVYAccessSupport.com

Together with GSK Oncology. At GSK, we understand that a cancer diagnosis can be overwhelming for patients and loved ones. Treatment considerations and costs can add undue stress, especially if you’re unsure what coverage options are available or how to access them. Together with GSK Oncology is here to help, offering patients and healthcare professionals a variety of access and reimbursement services for all GSK oncology products—all in one place.

Program Info: Togetherwithgskoncology.com

Visit the website for more information on Incyte's Patient Support Programs.

Program Info: IncyteCares.com

Reimbursement Contact:

Marcy Gingerich, Field Access Manager, McKesson (IncyteCares)

Phone: 740-405-2240 

E-mail: Marcy.Gingerich@McKesson.com

Drugs: 

Jakafi (ruxolitinib), Pemazyre (pemigatinib), Zynyz (retifanlimab-dlwr)

Janssen Compass is a new patient offering with a single point of contact for your patients, helping to clarify their path by providing information, education, and helping them become better advocates for themselves. Janssen Compass Program Overview.

Compass Info: https://www.janssencompass.com/

Janssen Care Path: For assistance regarding Darzalex (daratumumab), Yondelis (trabectedin), Zytiga (abiraterone acetate), Doxil (doxorubicin HCI liposome injection), Procrit (epoetin alfa), and Sylvant (siltuximab) 

Care Path Info: janssencarepath.com

Janssen advocacy organizations offer a range of different services, including financial support or transportation services. They may even be able to help you in ways you never expected. Use this tool to find organizations near you that can help.  

Janssen's Advocacy Connector: advocacyconnector.com

JazzCares provides access and reimbursement support to Jazz medications. See the downloadable handout for information. 

Contact: 1-833-533-JAZZ (5299)

Program Info: Jazzcares.com

KaryForward can assist with access and insurance coverage, financial assistance, and nurse care manager support.  KaryForward is here to help you every step of the way — from insurance coverage and financial assistance to support and resources — so you can focus on moving forward with your life.

1-877-KARY4WD (1-877-527-9493)

Program Info:  KaryForward.com

Reimbursement Contact:

Jacqueline Buckley, Corporate Account Director
85 Wells Avenue Suite 210, Newton MA 02459
Cell: 774-236-0231
E-Mail: jbuckley@karyopharm.com

Drugs: XPOVIO® (selinexor) www.XPOVIOpro.com

Lilly is dedicated to developing treatments, but we're more than just our medicines. We’re determined to do our part to help patients and their loved ones. Through the Lilly Oncology Support Center, we strive to offer personalized treatment support for eligible patients prescribed a Lilly Oncology product. 1-866-472-8663

Program Info:  Lilly Oncology Support Center

Lilly Cares® Foundation Patient Assistance Program. Helping patients with financial need receive their prescribed Eli Lilly and Company (Lilly) medications at no cost. 1-800-545-6962

Lilly Cares Info: lillycares.com

Drugs: Cyramza (ramucirumab), Alimta (pemetrexed), Erbitux (cetuximab),Retevmo (Selpercatinib), Verzenio (abemaciclib), Portrazza (necitumumab)

The Merck Access Program is here to help answer your questions about insurance and coverage after you have been prescribed KEYTRUDA by your healthcare provider. The Merck Access Program provides information and resources that you may find helpful. 1-855-257-3932

Program Info:  merckaccessprogram-keytruda.com

Patient Support: The KEY+YOU program is designed for patients prescribed KEYTRUDA (pembrolizumab) for an approved indication. Educational resources are provided to patients and caregivers to help you understand your treatment with KEYTRUDA (pembrolizumab) and be more active and vocal in your or your loved one’s care.

Program Info: KEY+YOU

Reimbursement Contact:

Mark Montello, Medicare Account Executive

E-mail: Mark.Montello@merck.com
Phone: 603-321-1145

Novartis Oncology Universal Co-pay Program: copay.novartisoncology.com

Novartis HCP Info: hcp.novartis.com/home

Reimbursement Contact:

Elizabeth Gugliotta, Associate Director Access & Reimbursement

E-mail: Elizabeth.Gugliotta@novartis.com

Cell: 401-480-9905

The Pfizer Patient Assistance Program (PAP) provides free medicines to eligible patients in need.

PAP Program Info: PfizerPAPConnect.com

Pfizer RxPathways connects eligible patients to assistance programs that offer insurance support, co-pay assistance, and medicines for free or at a saving. 

Drugs: Besponsa, Bosulif, Braftovi, Daurismo, Ibrance, Inlyta, Lorbrena, Mektovi, Mylotarg, Retacrit, Talzenna, Vizimpro, Xalkori

Pfizer RxPathways Info: Visit www.PfizerRxPathways.com or call the toll-free phone number 1-844-989-PATH (7284) to consult with a Pfizer Medicine Access Counselor.

Pfizer Oncology TogetherTM, we treat your individual needs as a priority. We’ll help you identify financial assistance options so you can get your prescribed TRAZIMERA. We can also connect you with a dedicated Care Champion who has social work experience and will offer resources that may help with some of your day-to-day challenges

Pfizer Oncology Together Info: trazimera.com/patientresources

MyHealthcareFinances: myhealthcarefinances.com

MyHealthcareFinances is a tool to help you better understand finances related to healthcare and steps you may take to lower your costs. Our goal is to provide an overview of key topics that may be helpful to you and point you in the right direction on where to find more information.

Reimbursement contact:

Julie Rogers, MBA, CRT, CPC, Field Reimbursement Manager

Phone: 860-422-0420
E-mail: Julie.rogers@pfizer.com

By Your Side* is a patient program designed specifically to support IMBRUVICA® (ibrutinib) prescribed patients. Prescribing Information: www.rxabbvie.com/pdf/imbruvica_pi.pdf

Program Info: By Your Side

LIBTAYO Surround Patient Support Program can help patients access LIBTAYO® (cemiplimab-rwlc) and navigate the health insurance process. It provides:

• Access and reimbursement support, including benefits investigation, prior authorization, and claims assistance
• Financial support, including the Patient Assistance Program and Commercial Copay Program
• Additional support through dedicated Patient Navigators, including appointment reminders, local support groups, transportation services, and educational resources

For more information, call LIBTAYO Surround at 1.877.LIBTAYO (1.877.542.8296) Option 1, Monday–Friday 8:00 AM–8:00 PM Eastern time.

Program Info: LIBTAYO Surround

RIGEL ONECARE is a patient support center whose nurse navigators provide support for patients prescribed TAVALISSE (fostamatinib disodium hexahydrate) tablets.

Contact RIGEL ONECARE at 833-744-3562 for more information about specific programs.  Patient Assistance Program Form.

Program Info:  RIGEL ONCECARE

TAVALISSE TOGETHER is a program for adult patients with chronic immune thrombocytopenia (ITP) who are taking or are interested in taking TAVALISSE. This program partners with patients throughout their treatment journey, helping them to become successful with their ITP treatment and achieve their goals.

Program Info: together.tavalisse.com

CareASSIST® Helping eligible patients access their prescribed medications.

Program Info: sanoficareassist.com

Reimbursement Contact:

Mike Brooks, Regional Account Manager
Phone: 484-686-9380
E-mail: mike.brooks@sanofi.com

Drugs: Sarclisa (isatuximab-irfc), Jevtana (Cabazitaxel), Elitek (Raspuricase)

ServierONE.com is your all-in-one resource for help with the cost of treatment, determining insurance coverage, one-on-one support, and access to additional resources and educational tools.  Email: PatientServices@servier.com

Program Information:  ServierONE.com

ServierONE is your all-in-one resource for help with the cost of treatment, determining insurance coverage, one-on-one support, and access to additional resources and educational tools. 

Email USPatientServices@servier.com or call 1-844-409-1141 (Tibsovo); 1-800-813-5905 (all other products).

Program Information:  ServierONE.com

Stemline ARC® provides access support, reimbursement assistance and educational resources to help patients and the healthcare professionals involved in their care, so patients can focus on what matters most—their health. Connect with a Stemline ARC Patient Advocate at 1-833-4-STEMLINE (1-833-478-3654), 9:00 AM to 6:00 PM ET, Monday through Friday, to learn more.

Program information: stemlinearc.com

Drugs: ORSERDU (elacestrant); ELZONRIS (tagraxofusp-erzs)